SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001600132-20-000009
Filing Date
2020-02-07
Accepted
2020-02-07 12:05:49
Documents
4
Period of Report
2020-02-05
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 8-K a8-kfebruary2020reversespl.htm 8-K 35184
2 EXHIBIT 3.1 certificateofamendmentexhi.htm EX-3.1 11872
3 EXHIBIT 99.1 pressreleasefebruary72020e.htm EX-99.1 13456
4 blphpica08.jpg GRAPHIC 14227
  Complete submission text file 0001600132-20-000009.txt   81504
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36845 | Film No.: 20586176
SIC: 2834 Pharmaceutical Preparations